|
"Genetic interactions between Tgfb1 and Skts15/Tgfbm3 in cancer"
|
5R01CA116019-02
|
$296,906
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
2008 International Symposium
|
1R13CA135806-01
|
$7,000
|
DONG, ZIGANG
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
A computer aided chromosome imaging technique for cancer diagnosis
|
5R01CA115320-03
|
$312,688
|
Liu, Hong
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
A High-Throughput Model for Human Melanoma
|
5R01CA121118-02
|
$189,600
|
HOLMEN, SHERI
|
NEVADA CANCER INSTITUTE
|
|
A mouse model for p120 downregulation in cancer
|
5R01CA111947-04
|
$287,369
|
REYNOLDS, ALBERT
|
VANDERBILT UNIVERSITY
|
|
A Mouse model of TGFbeta1 and ras oncogene interactions
|
5R01CA122109-03
|
$240,628
|
GLICK, ADAM
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
A mouse model of TGFbeta1 and tumor immunosurveillance in Squamous cell cancer
|
5R01CA117957-03
|
$215,636
|
GLICK, ADAM
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
A Non-Invasive Method to Distinguish Melanomas from Benign Skin Lesions
|
1R43CA128247-01A1
|
$100,000
|
Klukkert, Zachary
|
DERMATEX, LLC
|
|
A Novel Treatment to Target Tumor Mass for Eradicating Metastasis
|
1R43CA130182-01A1
|
$200,435
|
Bao, Yun
|
BIOCHAIN INSTITUTE, INC.
|
|
A program of immune-based treatments for cancer
|
2K24CA093670-06
|
$178,300
|
CARSON, WILLIAM
|
OHIO STATE UNIVERSITY
|
|
aAPC-Mediated NKT cell Modulation to Enhance Cancer Immunotherapy
|
1K01CA131487-01
|
$119,880
|
Webb, Tonya
|
JOHNS HOPKINS UNIVERSITY
|
|
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
|
5R01CA113796-03
|
$291,276
|
Frank, Markus
|
CHILDREN'S HOSPITAL BOSTON
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S1
|
$104,604
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S2
|
$250,000
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-33
|
$7,326,647
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Accuracy of In-vivo Confocal Imaging for Pigmented Lesion Diagnosis
|
5R44CA058054-06
|
$574,526
|
Eastman, Jay
|
LUCID, INC.
|
|
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
|
1P01CA128913-01A1
|
$1,670,604
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
Z01 BC 010984
|
$1,116,265
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Adoptive T Cell Therapy of Melanoma Targeting NY-ESO-1
|
5R01CA104711-05
|
$337,154
|
YEE, CASSIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center
|
2U01CA096230-06
|
$718,223
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
AIDS cancer match, non-U.S.
|
Z01 CP010176-10084
|
$188,362
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S1
|
$249,599
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S2
|
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S3
|
$250,067
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Corsortium
|
5U01CA121947-03
|
$3,732,363
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Akt3 Signaling as a Therapeutic Target
|
1R01CA127892-01A1
|
$313,325
|
ROBERTSON, GAVIN
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Altering Post Vaccination T Cell Contraction
|
5R01CA083672-08
|
$249,183
|
COLE, DAVID
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
American College of Radiology Imaging Network
|
2U01CA080098-10
|
$9,101,961
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
An Animal Model for Kaposi's Sarcoma
|
5K08CA103858-05
|
$133,083
|
PARSONS, CHRISTOPHER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
An RNA Sensor for Detection of Circulating Tumor Cells
|
5R33CA118591-03
|
$284,503
|
CLAWSON, GARY
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Analysis of CD8 T cell responses to tumors
|
5R01CA071833-11
|
$282,084
|
DUTTON, RICHARD
|
TRUDEAU INSTITUTE, INC.
|
|
Anatomic Pathology Residency Program
|
Z01 BC 010684
|
$1,300,000
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Animal Model and Genotyping Core Support Facility
|
Z01 BC 011047
|
$1,033,915
|
DuBois, Wendy
|
CCR (NCI)
|
|
Anti-melanoma Activity of Combined Lymphopenia and Immunotherapy
|
1K99CA128825-01A1
|
$105,494
|
Pilon-Thomas, Shari
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Anti-Tumor Autoimmunity by lymphopenia T cell Expansion
|
5R01CA109026-04
|
$328,921
|
BACCALA, ROBERTO
|
SCRIPPS RESEARCH INSTITUTE
|
|
Anti-viral IL6 approach to mitigate KSHV-related disease
|
1R01CA132638-01A1
|
$643,832
|
WONG, SCOTT
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Anticarcinogenic Mechanisms of Tea Constituents
|
2R37CA081064-09
|
$282,625
|
DONG, ZIGANG
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Antigen specificity, suppressive mechanism & regulation of CD4+ regulatory T cell
|
5R01CA116408-03
|
$258,529
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,350,223
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Antigenic Determinants on HLA-B7 and -A2
|
9R01CA134060-24A1
|
$379,773
|
ENGELHARD, VICTOR
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Antigens of Kaposi's sarcoma associated herpesvirus
|
2R01CA075911-12A1
|
$310,171
|
Chandran, Bala
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Antioxidant Enzymes and Cell Cycle Checkpoint Pathways
|
5R01CA111365-03
|
$203,376
|
GOSWAMI, PRABHAT
|
UNIVERSITY OF IOWA
|
|
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa
|
5R01CA119903-04
|
$480,231
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Antitumor Mechanisms of anti-CD40/CpG-activated Macrophages
|
2R01CA087025-05A2
|
$270,001
|
SONDEL, PAUL
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Apoptosis in Melanoma Progression and Chemoresistance
|
7R01CA107237-05
|
$167,942
|
SOENGAS, MARIA
|
SPANISH NATIONAL CANCER CENTER
|
|
Application of Nanotechnology in Photodynamic Therapy
|
5R01CA104492-04
|
$244,981
|
BERGEY, EARL
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Applications of "Recombomice" for Cancer Research
|
5R33CA112151-03
|
$272,319
|
ENGELWARD, BEVIN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Applying nanosecond pulse electric fields to treat skin cancer
|
1R01CA125722-01A2
|
$216,697
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S5
|
$3,963,721
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S6
|
$100,000
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|